News
U.S. FDA approves Alvotech and Teva’s SELARSDI, biosimilar to Stelara
The U.S. Food and Drug Administration (FDA) has approved Alvotech and Teva Pharmaceuticals' SELARSDI (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to Stelara®,...
Medincell enters into agreement with AbbVie to develop next-generation long-acting injectable therapies
Medincell has formed a collaboration with AbbVie to co-develop and commercialize up to six therapeutic products across multiple therapeutic areas and indications.
It will use...
ACG awarded ‘Great Place To Work’ certification for a fourth consecutive year
ACG, the world’s largest integrated supplier and service provider to the pharmaceutical industry, is delighted to announce that for the fourth consecutive year, it...
